INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 423m ago
HOUSE PTR23m ago
SEC 13F23m ago
ROBINHOOD CHAIN23m ago
Corporate insider
SM

Schmitt Daniel M

Director, President, CEO and DirectorCIK 0001318470

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells2 / 0
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Open-market purchase
BUY$50K
140.8K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ACTUATE THERAPEUTICS, INC.Director, President, CEO and Director · Aug 14, 2026
41
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Open-market purchase
BUY
—
70.4K sh
Oct 28, 2026
Oct 29, 2026
traded Oct 28, 2026
+1d
SEC FORM 4

Evidence

21
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence

9
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence

24
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Tax withholding
F$122K
120.5K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence